Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase III trial to compare the effectiveness of paclitaxel with that of
doxorubicin in treating patients who have advanced AIDS-related Kaposi's sarcoma. Drugs used
in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. It is not yet known whether paclitaxel is more effective than doxorubicin in treating
patients with advanced AIDS-related Kaposi's sarcoma